@FierceBiotech: Pfizer unveils $100M Boston effort to spark R&D innovation. News | Follow @FierceBiotech
@JohnCFierce: Quick shout out to the people who submitted close to 50 Fierce 15 nominations in the first 24 hours. Keep those cards and letters coming! Submission form | Follow @JohnCFierce
> Revance Therapeutics has closed a $45 million financing as the firm advances development of a topical gel form of botulinum toxin type A used to smooth wrinkles in the skin. Release
> The FDA has fast tracked Emergent BioSolutions's Phase I anthrax vaccine, called NuThrax. Emergent release
> Members of North Carolina's Senate Finance committee have once again proposed legislation that would provide funding to biotech start-ups. Critics say the Life Sciences Development Act puts the state in the business of taking on venture capitalists' risk. Report
> Biodefense company PharmAthene plans to sell $6.5 million of its common stock and warrants in a registered direct offering. PharmAthene release
> A novel variant of swine flu has emerged in Asia with a genetic adaptation giving some resistance to Roche's Tamiflu and GlaxoSmithKline's Relenza, the two mainstay drugs used to tackle the disease. Article
Pharma News
@FiercePharma: France suspends Takeda's Actos on cancer data. Item | Follow @FiercePharma
> FTC mulls agency action against pay-for-delay. Article
> UCB to pay $34M for off-label marketing. Story
> Hong Kong yanks GSK drug on phthalate levels. Item
> Germany joins in suspension of Takeda's Actos. Report
Most Popular This Week
> Alzheimer's biomarker market to reach $9B in decade. Item
> Pfizer embarks on a 'first' all-electronic clinical trial. Story
> Roche, Merck to collaborate on cancer diagnostics. Article
> FDA steps in to prevent drug shortages. Report
> Obesity vaccine would suppress hunger hormone. Story
> Cholera molecule helps cocaine addicts kick the habit. Article
> Adult vaccines cut down on healthcare costs. Piece
> Pfizer plots another $1B in cost cuts. Article
> Pfizer unveils $100M Boston effort to spark R&D innovation. Report
And Finally... Orphan diseases are a result of mutations to genes essential to survival, according to research reported in the American Journal of Human Genetics. Report